Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Moretti

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Vaccine: X|July 23, 2024
Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational studyDiana Dalla Valle, Roberto Benoni, Nicola Soriolo, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Health Science Reports|April 23, 2026
Patients' Associations as Co-Creators of Knowledge: Insights From a Community-Based Participatory Research Study (ProSafe Project)Francesca Moretti, Silvia Colpo, Sara Montresor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2011
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomasElisabetta Botti, Giulia Spallone, Francesca Moretti, et al.
The Journal of Experimental Medicine|February 20, 2013
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosisRubeta N Matin, Anissa Chikh, Stephanie Law Pak Chong, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
Frontiers in Surgery|August 27, 2025
Impact of nursing robotic assisted surgery education on Kirkpatrick's four levelsMaria Angela Cerruto, Elisabetta Veronese, Francesca Moretti, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2024
Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin DeficiencyJie Li, Francesca Moretti, Tunda Hidvegi, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patientsDora Larussa, Patrizia Lorenzini, Antonella Cingolani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) studyCarlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Vaccine: X|July 23, 2024
Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational studyDiana Dalla Valle, Roberto Benoni, Nicola Soriolo, et al.
The Journal of Clinical Investigation|April 29, 2010
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasiasFrancesca Moretti, Barbara Marinari, Nadia Lo Iacono, et al.
Health Science Reports|April 23, 2026
Patients' Associations as Co-Creators of Knowledge: Insights From a Community-Based Participatory Research Study (ProSafe Project)Francesca Moretti, Silvia Colpo, Sara Montresor, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2011
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomasElisabetta Botti, Giulia Spallone, Francesca Moretti, et al.
The Journal of Experimental Medicine|February 20, 2013
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosisRubeta N Matin, Anissa Chikh, Stephanie Law Pak Chong, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patientsLuca Quagliata, Matthias S Matter, Salvatore Piscuoglio, et al.
Frontiers in Surgery|August 27, 2025
Impact of nursing robotic assisted surgery education on Kirkpatrick's four levelsMaria Angela Cerruto, Elisabetta Veronese, Francesca Moretti, et al.
Cellular and Molecular Gastroenterology and Hepatology|February 9, 2024
Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin DeficiencyJie Li, Francesca Moretti, Tunda Hidvegi, et al.
AIDS Research and Human Retroviruses|May 19, 2006
Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patientsDora Larussa, Patrizia Lorenzini, Antonella Cingolani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2005
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) studyCarlo Torti, Eugenia Quiros-Roldan, Mario Regazzi, et al.
Pageof 11